This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Add Cabot (CBT) Stock to Your Portfolio
by Anindya Barman
Healthy growth prospects and upbeat outlook make Cabot (CBT) an attractive investment option.
Eastman Chemical (EMN) to Raise Price of Choline Chloride
by Zacks Equity Research
Eastman Chemical (EMN) is taking appropriate actions amid an escalated raw material pricing environment.
Zacks.com highlights: ArcBest, Cabot, Avianca Holdings, PetroChina and Finish Line
by Zacks Equity Research
Zacks.com highlights: ArcBest, Cabot, Avianca Holdings, PetroChina and Finish Line
Tap 5 Value Stocks Sporting Enticing EV/EBITDA Ratios
by Zacks Equity Research
We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Here's Why You Should Add Praxair (PX) to Your Portfolio
by Zacks Equity Research
Praxair (PX) stands to gain from a solid product portfolio and increasing applications of industrial gases. Returning value to shareholders is a priority.
Mosaic (MOS) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Solid performance across all segments contributed to Mosaic's (MOS) results in Q4.
Agnico Eagle (AEM) Tops on Q4 Earnings, Ups Production View
by Zacks Equity Research
While Agnico Eagle (AEM) has raised its production view for 2018, it sees a year-over-year increase in AISC this year.
Air Products to Buy Europe's Leading Carbon Dioxide Business
by Zacks Equity Research
Air Products' (APD) latest deal will help the company to foray into newer regions of Europe as a liquid carbon dioxide supplier.
Celanese (CE) Set to Raise Price of Low Density Polyethylene
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment which are likely to lend support to its margins.
Kinross (KGC) Misses Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Kinross' (KGC) results are adversely impacted by lower gold production in Q4.
Cabot (CBT) Earnings & Revenues Surpass Estimates in Q1
by Zacks Equity Research
Solid segment performances contributed to Cabot's (CBT) results in Q1.
Chemical Stock Earnings to Watch on Feb 6: AXTA, CBT & More
by Zacks Equity Research
Most of the chemical stocks reporting earnings on Feb 6 are unlikely to impress.
Why Cabot Corp. (CBT) Might Surprise This Earnings Season
by Zacks Equity Research
Cabot (CBT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Is a Beat in the Cards for Cabot Corp (CBT) in Q1 Earnings?
by Zacks Equity Research
Growth-focused investments are likely to support Cabot Corp's (CBT) earnings in Q1.
4 Chemical Stocks Well Poised to Trump Earnings Estimates
by Zacks Equity Research
Chemical makers continue to see strong demand from construction and automotive sectors - major chemical end-use markets.
Cabot Corp (CBT) Q4 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
Cabot (CBT) reported a year-over-year decrease in adjusted earnings for fiscal fourth quarter that missed the Zacks Consensus Estimate.
Mosaic's (MOS) Earnings and Revenues Top Estimates in Q3
by Zacks Equity Research
Strong operational performance and better price realization boosted Mosaic's (MOS) bottom line in Q3.
Will Higher Shipments Drive WestRock (WRK) Q4 Earnings?
by Zacks Equity Research
WestRock's (WRK) fourth-quarter fiscal 2017 results will benefit from seasonally higher volumes, sales price increases, favorable mix and productivity. However, higher input costs will dent results.
Can CVR Partners (UAN) Spring a Surprise in Q3 Earnings?
by Zacks Equity Research
Weak nitrogen prices are likely to dent CVR Partners' (UAN) earnings in Q3.
Goldcorp's (GG) Q3 Earnings In Line, Revenues Miss Estimates
by Zacks Equity Research
Strong operating performance at Cerro Negro and Penasquito drives Goldcorp's (GG) third-quarter 2017 earnings.
Agnico-Eagle (AEM) Q3 Earnings Top, Ups Production Outlook
by Zacks Equity Research
Record gold production and strong cash flow drives Agnico-Eagle's (AEM) Q3 performance.
Should You Buy Cabot Corporation (CBT) Ahead of Earnings?
by Zacks Equity Research
Cabot Corporation (CBT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Is a Beat in the Cards for Cabot Corp (CBT) in Q4 Earnings?
by Zacks Equity Research
Cabot Corp's (CBT) fourth-quarter fiscal 2017 earnings are expected to gain from higher volumes across performance chemicals' end markets and lower fixed costs in purification solutions.
4 Chemical Stocks Well Poised to Top Earnings Estimates
by Zacks Equity Research
The chemical industry has so far enjoyed a positive run this year.
Freeport (FCX) Tops Earnings, Revenue Estimates in Q3
by Zacks Equity Research
Freeport's (FCX) adjusted earnings of 36 cents in third-quarter 2017 beat the Zacks Consensus Estimate of 29 cents. The company gained from higher copper prices and its cost management actions.